110 related articles for article (PubMed ID: 10080396)
1. Deferoxamine effects on Plasmodium falciparum gene expression.
Moormann AM; Hossler PA; Meshnick SR
Mol Biochem Parasitol; 1999 Jan; 98(2):279-83. PubMed ID: 10080396
[No Abstract] [Full Text] [Related]
2. Antimalarial effect of iron chelators.
Gordeuk VR; Loyevsky M
Adv Exp Med Biol; 2002; 509():251-72. PubMed ID: 12572998
[No Abstract] [Full Text] [Related]
3. In vitro antimalarial effect of daphnetin relating to its iron-chelating activity.
Mu LY; Wang QM; Ni YC
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2002; 20(2):83-5. PubMed ID: 12567565
[TBL] [Abstract][Full Text] [Related]
4. Malaria pigment and extracellular iron. Possible target for iron chelating agents.
van Zyl RL; Havlik I; Hempelmann E; MacPhail AP; McNamara L
Biochem Pharmacol; 1993 Apr; 45(7):1431-6. PubMed ID: 8471067
[TBL] [Abstract][Full Text] [Related]
5. The combined effect of iron chelators and classical antimalarials on the in-vitro growth of Plasmodium falciparum.
van Zyl RL; Havlik I; Monteagudo FS
J Antimicrob Chemother; 1992 Sep; 30(3):273-8. PubMed ID: 1452491
[TBL] [Abstract][Full Text] [Related]
6. Mode of action of iron (III) chelators as antimalarials. IV. Potentiation of desferal action by benzoyl and isonicotinoyl hydrazone derivatives.
Tsafack A; Loyevsky M; Ponka P; Cabantchik ZI
J Lab Clin Med; 1996 Jun; 127(6):574-82. PubMed ID: 8648262
[TBL] [Abstract][Full Text] [Related]
7. Growth inhibition of Plasmodium falciparum involving carbon centered iron-chelate radical (L., X-)-Fe(III) based on pyridoxal-betaine. A novel type of antimalarials active against chloroquine-resistant parasites.
Iheanacho EN; Sarel S; Samuni A; Avramovici-Grisaru S; Spira DT
Free Radic Res Commun; 1991; 15(1):1-10. PubMed ID: 1663064
[TBL] [Abstract][Full Text] [Related]
8. Antimalarial iron chelator FBS0701 blocks transmission by Plasmodium falciparum gametocyte activation inhibition.
Ferrer P; Vega-Rodriguez J; Tripathi AK; Jacobs-Lorena M; Sullivan DJ
Antimicrob Agents Chemother; 2015 Mar; 59(3):1418-26. PubMed ID: 25512427
[TBL] [Abstract][Full Text] [Related]
9. Mode of action of iron (III) chelators as antimalarials: I. Membrane permeation properties and cytotoxic activity.
Lytton SD; Mester B; Dayan I; Glickstein H; Libman J; Shanzer A; Cabantchik ZI
Blood; 1993 Jan; 81(1):214-21. PubMed ID: 8417790
[TBL] [Abstract][Full Text] [Related]
10. Antimalarial action of hydroxamate-based iron chelators and potentiation of desferrioxamine action by reversed siderophores.
Golenser J; Tsafack A; Amichai Y; Libman J; Shanzer A; Cabantchik ZI
Antimicrob Agents Chemother; 1995 Jan; 39(1):61-5. PubMed ID: 7695330
[TBL] [Abstract][Full Text] [Related]
11. Malaria: to kill a parasite.
Ridley RG
Nature; 2003 Aug; 424(6951):887-9. PubMed ID: 12931167
[No Abstract] [Full Text] [Related]
12. In vitro activity of iron-binding compounds against Senegalese isolates of Plasmodium falciparum.
Pradines B; Tall A; Ramiandrasoa F; Spiegel A; Sokhna C; Fusai T; Mosnier J; Daries W; Trape JF; Kunesch G; Parzy D; Rogier C
J Antimicrob Chemother; 2006 Jun; 57(6):1093-9. PubMed ID: 16595639
[TBL] [Abstract][Full Text] [Related]
13. Unique properties of respiratory chain in Plasmodium falciparum mitochondria.
Mi-Ichi F; Takeo S; Takashima E; Kobayashi T; Kim HS; Wataya Y; Matsuda A; Torrii M; Tsuboi T; Kita K
Adv Exp Med Biol; 2003; 531():117-33. PubMed ID: 12916785
[No Abstract] [Full Text] [Related]
14. Plasmodium falciparum: inhibition in vitro with lactoferrin, desferriferrithiocin, and desferricrocin.
Fritsch G; Sawatzki G; Treumer J; Jung A; Spira DT
Exp Parasitol; 1987 Feb; 63(1):1-9. PubMed ID: 3542546
[TBL] [Abstract][Full Text] [Related]
15. Effects of hydroxypyridinone iron chelators in combination with antimalarial drugs on the in vitro growth of Plasmodium falciparum.
Pattanapanyasat K; Kotipun K; Yongvanitchit K; Hider RC; Kyle DE; Heppner DG; Walsh DS
Southeast Asian J Trop Med Public Health; 2001 Mar; 32(1):64-9. PubMed ID: 11485097
[TBL] [Abstract][Full Text] [Related]
16. Iron chelators: mode of action as antimalarials.
Cabantchik ZI; Glickstein H; Golenser J; Loyevsky M; Tsafack A
Acta Haematol; 1996; 95(1):70-7. PubMed ID: 8604590
[TBL] [Abstract][Full Text] [Related]
17. Iron chelation therapy for malaria.
Gordeuk VR; Thuma PE; Brittenham GM
Adv Exp Med Biol; 1994; 356():371-83. PubMed ID: 7887243
[No Abstract] [Full Text] [Related]
18. Plasmodium falciparum and Plasmodium yoelii: effect of the iron chelation prodrug dexrazoxane on in vitro cultures.
Loyevsky M; Sacci JB; Boehme P; Weglicki W; John C; Gordeuk VR
Exp Parasitol; 1999 Feb; 91(2):105-14. PubMed ID: 9990337
[TBL] [Abstract][Full Text] [Related]
19. Plasmodium falciparum: inhibition of in vitro growth by desferrioxamine.
Raventos-Suarez C; Pollack S; Nagel RL
Am J Trop Med Hyg; 1982 Sep; 31(5):919-22. PubMed ID: 6751113
[TBL] [Abstract][Full Text] [Related]
20. Effects of synthetic siderophores on proliferation of Plasmodium falciparum in infected human erythrocytes.
Rotheneder A; Fritsche G; Heinisch L; Möllmann U; Heggemann S; Larcher C; Weiss G
Antimicrob Agents Chemother; 2002 Jun; 46(6):2010-3. PubMed ID: 12019128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
